A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...
More than 55 million people are currently living with dementia. Research into possible preventatives and treatments can’t ...
In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...
Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...
New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective.
There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...
The Alzheimer's Association says more than 122,000 Missourians 65 years and older are battling Alzheimer's Disease, which has ...
Feeling sleepy and less enthusiastic during the day may indicate a higher risk of developing a syndrome that often leads to ...
Health system changes that bolster access to disease-modifying treatments for Alzheimer’s disease could reduce the disparities in diagnosis and improve health equity in disease treatment overall, ...
The ability to possibly detect Alzheimer’s disease before symptoms emerge using blood-based biomarkers has introduced new ...
Two new laws spearheaded by Sen. Susan Collins – signed into law on Oct. 1 – will continue to infuse federal funding into ...
Alzheimer's is generally characterised by memory loss and other cognitive abilities serious enough to interfere with daily ...